Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients (Q71169983)
Jump to navigation
Jump to search
scientific article published on 01 July 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients |
scientific article published on 01 July 1996 |
Statements
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients (English)
A L Børresen
1 reference
L A Akslen
1 reference
J E Varhaug
1 reference
H Johnsen
1 reference
S Geisler
B Smith-Sørensen